NO20021747D0 - Blandinger av erytromycinderivater med forlenget frigivelse - Google Patents
Blandinger av erytromycinderivater med forlenget frigivelseInfo
- Publication number
- NO20021747D0 NO20021747D0 NO20021747A NO20021747A NO20021747D0 NO 20021747 D0 NO20021747 D0 NO 20021747D0 NO 20021747 A NO20021747 A NO 20021747A NO 20021747 A NO20021747 A NO 20021747A NO 20021747 D0 NO20021747 D0 NO 20021747D0
- Authority
- NO
- Norway
- Prior art keywords
- extended release
- erythromycin derivatives
- release erythromycin
- derivatives
- extended
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/416,916 US6551616B1 (en) | 1997-04-11 | 1999-10-13 | Extended release formulations of erythromycin derivatives |
PCT/US2000/028407 WO2001026663A1 (en) | 1999-10-13 | 2000-10-13 | Extended release formulations of erythromycin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20021747D0 true NO20021747D0 (no) | 2002-04-12 |
Family
ID=23651825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021747A NO20021747D0 (no) | 1999-10-13 | 2002-04-12 | Blandinger av erytromycinderivater med forlenget frigivelse |
Country Status (14)
Country | Link |
---|---|
US (3) | US6551616B1 (xx) |
EP (1) | EP1223949A1 (xx) |
KR (1) | KR20020068522A (xx) |
AR (1) | AR026045A1 (xx) |
AU (1) | AU1203601A (xx) |
BG (1) | BG106683A (xx) |
BR (1) | BR0010485A (xx) |
CA (1) | CA2387621A1 (xx) |
HU (1) | HUP0203540A3 (xx) |
IL (1) | IL149033A0 (xx) |
NO (1) | NO20021747D0 (xx) |
PL (1) | PL354783A1 (xx) |
SK (1) | SK4862002A3 (xx) |
WO (1) | WO2001026663A1 (xx) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6551616B1 (en) * | 1997-04-11 | 2003-04-22 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
PL366021A1 (en) * | 2000-02-29 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6878751B1 (en) * | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
US6642276B2 (en) * | 2001-10-01 | 2003-11-04 | M/S Ind-Swift Limited | Controlled release macrolide pharmaceutical formulations |
SI1551372T1 (en) * | 2002-09-20 | 2018-08-31 | Alpharma Pharmaceuticals Llc | SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES |
US9561182B2 (en) * | 2003-08-22 | 2017-02-07 | Cure Pharmaceutical Corporation | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals |
US20040191302A1 (en) | 2003-03-28 | 2004-09-30 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US20040131662A1 (en) | 2003-11-12 | 2004-07-08 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009365A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009368A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20050025825A1 (en) * | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
WO2005016311A1 (en) * | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005023184A2 (en) | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
BRPI0416534A (pt) * | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | composições multiparticuladas com estabilidade melhorada |
WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
RU2006119453A (ru) * | 2003-12-04 | 2007-12-20 | Пфайзер Продактс Инк. (Us) | Получение посредством основанных на применении жидкостей способов лекарственные формы азитромицина с большим количеством частиц |
WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
AU2004294813A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride |
US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
ATE399536T1 (de) * | 2003-12-04 | 2008-07-15 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
BRPI0417348A (pt) * | 2003-12-04 | 2007-03-13 | Pfizer Prod Inc | processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo |
US20050142187A1 (en) * | 2003-12-24 | 2005-06-30 | Treacy Donald J.Jr. | Enhanced absorption of modified release dosage forms |
US20090215898A1 (en) * | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050245614A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050260263A1 (en) * | 2004-05-18 | 2005-11-24 | Panion & Bf Biotech Inc. | Sustained release formulation for sparingly soluble main drugs |
WO2006014427A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2007143507A2 (en) * | 2006-06-05 | 2007-12-13 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted erythromycin analogs |
DK2526932T3 (en) * | 2006-06-19 | 2017-07-17 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
EP2073797A2 (en) * | 2006-10-11 | 2009-07-01 | Alpharma, Inc. | Pharmaceutical compositions |
EP2224808A4 (en) * | 2007-12-17 | 2013-11-27 | Alpharma Pharmaceuticals Llc | PHARMACEUTICAL COMPOSITION |
EP2224805A4 (en) * | 2007-12-17 | 2013-10-16 | Alpharma Pharmaceuticals Llc | PHARMACEUTICAL COMPOSITION |
US8623418B2 (en) * | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
US20100151014A1 (en) * | 2008-12-16 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
GB0903262D0 (en) * | 2009-02-26 | 2009-04-08 | Johnson Matthey Plc | Filter |
US20100280117A1 (en) * | 2009-04-30 | 2010-11-04 | Xanodyne Pharmaceuticals, Inc. | Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders |
MX2012006265A (es) * | 2009-12-03 | 2012-07-25 | Opko Health Inc | Formulaciones disacaridas hipersulfatadas. |
WO2018035050A1 (en) | 2016-08-16 | 2018-02-22 | Opko Pharmaceuticals, Llc | Pure heptasulfated disaccharides having improved oral bioavailability |
US10213394B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US20190247331A1 (en) | 2018-02-15 | 2019-08-15 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság | Composition and method for treating neurological disease |
US10213393B1 (en) | 2018-02-15 | 2019-02-26 | Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság | Composition and method for treating neurological disease |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065143A (en) | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
US3870790A (en) | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
US4226849A (en) | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
US4369172A (en) | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
FI69254C (fi) | 1984-02-01 | 1986-01-10 | Lujari Instmsto Oy | Anordning foer avskiljande av fasta aemnen fraon avfallsvatten |
DE3583799D1 (de) | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
FR2585948B1 (fr) | 1985-08-06 | 1988-12-16 | Pf Medicament | Procede de fabrication de comprimes d'indometacine |
DE3613799C1 (de) * | 1986-04-24 | 1987-09-03 | Nattermann A & Cie | Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln |
US4808411A (en) | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
JPH01308223A (ja) | 1988-02-22 | 1989-12-12 | Taisho Pharmaceut Co Ltd | 均質な微細皮膜製剤の製造方法 |
US4925675A (en) | 1988-08-19 | 1990-05-15 | Himedics, Inc. | Erythromycin microencapsulated granules |
US4925765A (en) * | 1988-12-23 | 1990-05-15 | E. I. Du Pont De Nemours And Company | Negative solid block toner |
US5017383A (en) | 1989-08-22 | 1991-05-21 | Taisho Pharmaceutical Co., Ltd. | Method of producing fine coated pharmaceutical preparation |
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
TW271400B (xx) * | 1992-07-30 | 1996-03-01 | Pfizer | |
US5393765A (en) | 1993-12-13 | 1995-02-28 | Hoffmann-La Roche Inc. | Pharmaceutical compositions with constant erosion volume for zero order controlled release |
CN1096862C (zh) | 1994-05-06 | 2002-12-25 | 辉瑞大药厂 | 阿齐霉素的控释剂型 |
US5919489A (en) | 1995-11-01 | 1999-07-06 | Abbott Laboratories | Process for aqueous granulation of clarithromycin |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
DE19706979A1 (de) | 1997-02-21 | 1998-08-27 | Lindopharm Gmbh | Kombinationspräparat für oral applizierbare Erythromycine |
DE19706978A1 (de) | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Kombinationspräparat für oral applizierbare Antibiotika |
US6551616B1 (en) * | 1997-04-11 | 2003-04-22 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
US6010718A (en) | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
EP0943341A1 (en) | 1998-02-18 | 1999-09-22 | Oscar Gold | Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides |
-
1999
- 1999-10-13 US US09/416,916 patent/US6551616B1/en not_active Expired - Lifetime
-
2000
- 2000-10-13 WO PCT/US2000/028407 patent/WO2001026663A1/en not_active Application Discontinuation
- 2000-10-13 AR ARP000105406A patent/AR026045A1/es unknown
- 2000-10-13 EP EP00973534A patent/EP1223949A1/en not_active Withdrawn
- 2000-10-13 CA CA002387621A patent/CA2387621A1/en not_active Abandoned
- 2000-10-13 AU AU12036/01A patent/AU1203601A/en not_active Abandoned
- 2000-10-13 BR BR0010485-0A patent/BR0010485A/pt not_active Application Discontinuation
- 2000-10-13 KR KR1020027004725A patent/KR20020068522A/ko not_active Application Discontinuation
- 2000-10-13 IL IL14903300A patent/IL149033A0/xx unknown
- 2000-10-13 PL PL00354783A patent/PL354783A1/xx not_active Application Discontinuation
- 2000-10-13 SK SK486-2002A patent/SK4862002A3/sk unknown
- 2000-10-13 HU HU0203540A patent/HUP0203540A3/hu unknown
-
2002
- 2002-04-12 NO NO20021747A patent/NO20021747D0/no unknown
- 2002-05-09 BG BG106683A patent/BG106683A/bg unknown
- 2002-11-22 US US10/302,166 patent/US6872407B2/en not_active Expired - Lifetime
-
2005
- 2005-03-28 US US11/091,637 patent/US20060039969A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SK4862002A3 (en) | 2002-10-08 |
US6551616B1 (en) | 2003-04-22 |
KR20020068522A (ko) | 2002-08-27 |
IL149033A0 (en) | 2002-11-10 |
US20060039969A1 (en) | 2006-02-23 |
AU1203601A (en) | 2001-04-23 |
HUP0203540A2 (hu) | 2003-02-28 |
BR0010485A (pt) | 2002-08-20 |
BG106683A (bg) | 2002-12-29 |
US6872407B2 (en) | 2005-03-29 |
AR026045A1 (es) | 2002-12-26 |
WO2001026663A1 (en) | 2001-04-19 |
EP1223949A1 (en) | 2002-07-24 |
US20030133981A1 (en) | 2003-07-17 |
PL354783A1 (en) | 2004-02-23 |
CA2387621A1 (en) | 2001-04-19 |
HUP0203540A3 (en) | 2003-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021747D0 (no) | Blandinger av erytromycinderivater med forlenget frigivelse | |
NO20000885L (no) | 4-Fenyl-pyridin-derivater | |
NO20021077D0 (no) | Amino-triazolopyridin-derivater | |
ATE263748T1 (de) | Admantan-derivate | |
DE50010060D1 (de) | Thiazolylamid-derivate | |
IS6128A (is) | 13-Metýl-erýþrómýsín afleiður | |
DK1187814T3 (da) | 5-phenyl-pyrimidinderivater | |
ATE338021T1 (de) | Substituierte 2-dialkylaminoalkylbiphenyl- derivate | |
NO20021803L (no) | Isoksazolkarboksamid-derivater | |
ATE257148T1 (de) | Propargyletherderivate | |
NO20014362D0 (no) | Erytromycinderivater | |
DK1154988T3 (da) | Mevinolinderivater | |
ATE374747T1 (de) | Monofluoralkylderivate | |
ATE293592T1 (de) | Resorcinderivate | |
DK1218340T3 (da) | 4-hydroxybiphenylhydrazid-derivater | |
DK1187815T3 (da) | 4-phenyl-pyrimidinderivater | |
NO20022867D0 (no) | Syklopentenon-derivater | |
NO20020212L (no) | 3-amino-2-benzyl-1-fenyl-propanderivater | |
PT1194401E (pt) | Derivados de diacil-hidrazina | |
PT1088818E (pt) | Derivados de quinolin-4-ilo | |
DK1189886T3 (da) | Ethansulfonyl-piperidinderivater | |
DE60001736D1 (de) | 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate | |
ATE269328T1 (de) | 1-cycloalkylpyrazolyl-benzoyl-derivate |